KAT6A, lysine acetyltransferase 6A, 7994

N. diseases: 129; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 Biomarker disease GENOMICS_ENGLAND KAT6A Syndrome: genotype-phenotype correlation in 76 patients with pathogenic KAT6A variants. 30245513 2019
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 GermlineCausalMutation disease ORPHANET De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. 25728775 2015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 Biomarker disease GENOMICS_ENGLAND De novo nonsense mutations in KAT6A, a lysine acetyl-transferase gene, cause a syndrome including microcephaly and global developmental delay. 25728775 2015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 Biomarker disease GENOMICS_ENGLAND Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. 25728777 2015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 GermlineCausalMutation disease ORPHANET Dominant mutations in KAT6A cause intellectual disability with recognizable syndromic features. 25728777 2015
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 GeneticVariation disease CLINVAR
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 CausalMutation disease CLINVAR
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 Biomarker disease CTD_human
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32
0.700 Biomarker disease GENOMICS_ENGLAND
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.300 Biomarker group CTD_human Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. 29662167 2018
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.300 Biomarker disease CTD_human Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets. 29662167 2018
CUI: C0010606
Disease: Adenoid Cystic Carcinoma
Adenoid Cystic Carcinoma
0.300 Biomarker disease CTD_human The mutational landscape of adenoid cystic carcinoma. 23685749 2013
Acute myeloid leukemia with t(8;16)(p11;p13) translocation
0.300 FusionGene disease ORPHANET Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group. 23974201 2013
CUI: C0025149
Disease: Medulloblastoma
Medulloblastoma
0.300 Biomarker disease CTD_human Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. 19270706 2009
CUI: C0205833
Disease: Medullomyoblastoma
Medullomyoblastoma
0.300 Biomarker disease CTD_human Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. 19270706 2009
CUI: C0278510
Disease: Childhood Medulloblastoma
Childhood Medulloblastoma
0.300 Biomarker disease CTD_human Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. 19270706 2009
CUI: C0278876
Disease: Adult Medulloblastoma
Adult Medulloblastoma
0.300 Biomarker disease CTD_human Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. 19270706 2009
CUI: C0751291
Disease: Desmoplastic Medulloblastoma
Desmoplastic Medulloblastoma
0.300 Biomarker disease CTD_human Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. 19270706 2009
CUI: C1275668
Disease: Melanotic medulloblastoma
Melanotic medulloblastoma
0.300 Biomarker disease CTD_human Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. 19270706 2009
Acute myeloid leukemia with t(8;16)(p11;p13) translocation
0.300 FusionGene disease ORPHANET Two novel variants of MOZ-CBP fusion transcripts in spontaneously remitted infant leukemia with t(1;16;8)(p13;p13;p11), a new variant of t(8;16)(p11;p13). 18698081 2008
CUI: C0012236
Disease: DiGeorge Syndrome
DiGeorge Syndrome
0.200 Biomarker disease MGD Here we show that lack of the histone acetyltransferase MOZ (MYST3/KAT6A) phenocopies DiGeorge syndrome, and the MOZ complex occupies the Tbx1 locus, promoting its expression and histone 3 lysine 9 acetylation. 22921202 2012
CUI: C0023904
Disease: Liver Neoplasms, Experimental
Liver Neoplasms, Experimental
0.200 Biomarker phenotype RGD Histone acetyltransferase MOZ acts as a co-activator of Nrf2-MafK and induces tumour marker gene expression during hepatocarcinogenesis. 17083329 2007
CUI: C0012236
Disease: DiGeorge Syndrome
DiGeorge Syndrome
0.200 Biomarker disease MGD Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells. 16651658 2006
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.130 Biomarker disease BEFREE Pathogenic variants in KAT6A have recently been identified as a cause of syndromic developmental delay. 30245513 2019
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.130 GeneticVariation disease BEFREE A KAT6A variant in a family with autosomal dominantly inherited microcephaly and developmental delay. 29899504 2018